Medicated IUS

Description: An intrauterine system (IUS) containing a progestin - likely etonogestrel.

Product Details

User: Female

Hormonal: Yes

Delivery Method: Intrauterine

Duration Type: Long-acting

Dose: 38mg, 61mg or 72mg

Active Pharmaceutical Ingredient (API):
  • etonogestrel

Multipurpose Preventive Technology (MPT): No

Status Details

Developer: Merck

Project Phase: Pre-Clinical and Clinical Development

Development Stage: Phase II

Active Development: Unknown

Status Details:
  • Phase II studies were completed in July 2011 to test different quantities of etonogestrel (38mg, 61mg, 72mg) and different thicknesses of the reservoir's membrane (350 μm, 140 μm, and 50 μm), respectively. This work was done under authority of the European Medicines Agency.

Additional Information


Vertical Tabs